I have been repeatedly writing posts regarding Dr. Jeanne Loring, Aspen Neuroscience, and/or stem cell trials since joining this forum more than five years ago. I'm glad it's finally more than just an encouraging talking point.
"The U.S. Food and Drug Administration (FDA) has given Aspen Neuroscience clearance to launch a clinical trial of ANPD001, an experimental stem cell therapy designed to replace the nerve cells that are lost in Parkinson’s disease."
parkinsonsnewstoday.com/new...
what I don't understand is why is Aspen getting all the press on this when Hope Biosciences has been working on this for years
Apples and oranges. Aspen will be injecting iPSC-derived dopamine neurons directly into the brain. Hope Biosciences is injecting mesenchymal stem cells into a vein.
There will be plenty of "press" for Hope Biosciences (and Uni of Texas) if they publish anything of significance.
I guess from reading the information on their page I didn't realize that they were injecting them into the brain
It should be a bit clearer once they post a study record on the Clinical Trials website.
Just when we were starting to think it would never happen. it'll be 10 years, but that would be aged 72 for me. there are a few others under way, including Roger Barkers. Good to have stuff in the pipeline. just got to hang in there meantime. The gloves are helping me do that a lot at the moment
I get the sense that stem cells are going to explode the way medical marijuana did.
Good Evening,
My reply maybe a bit late to the topic, but what about the therapy from Trinity Clinic Fukuoka in Japan involving 10 intravenously administered doses of 200 million autologous adipose tissue-derived Mesenchymal Stem Cells over two hours. This is repeated every fortnight until 10 treatments are completed. In order to reduce the risk of graft-versus-host disease, the patient’s own stem cells are used.
The stem cells are extracted from patients’ own (autologous) fat, or adipose, tissue. Following extraction, the cells are expanded in the laboratory until they reach high numbers, and injected back into patients’ blood.
This is the correct way to use stem cells, over several courses of treatment, not just one or two as most clinics use.
